KIR3DL1 and acute leukemia: However, a recent study from the European Society for Blood and Marrow Transplantation (EBMT) that included 444 patients with acute leukemia showed that KIR ligand mismatch may be associated with a higher risk of relapse and was associated with significantly worse survival (26).